ENTL Entellus Medical Inc

ENTELLUS MEDICAL, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout

WILMINGTON, Del.--(BUSINESS WIRE)--

Rigrodsky & Long, P.A.:

  • Do you own shares of Entellus Medical, Inc. (NASDAQ GM: ENTL)?
  • Did you purchase any of your shares prior to December 7, 2017?
  • Do you think the proposed buyout is fair?
  • Do you want to discuss your rights?

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Entellus Medical, Inc. (“Entellus” or the “Company”) (NASDAQ GM: ENTL) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by Stryker Corporation (“Stryker”) (NYSE: SYK) in a transaction valued at approximately $662 million. Under the terms of the agreement, shareholders of Entellus will receive $24.00 in cash for each share of Entellus common stock.

If you own common stock of Entellus and purchased any shares before December 7, 2017, if you would like to learn more about this investigation, or if you have any questions concerning this announcement or your rights or interests, please contact Seth D. Rigrodsky or Gina M. Serra at Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803, by telephone at (888) 969-4242, or by e-mail at [email protected].

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly prosecutes securities fraud, shareholder corporate, and shareholder derivative litigation on behalf of shareholders in state and federal courts throughout the United States.

Attorney advertising. Prior results do not guarantee a similar outcome.

EN
07/12/2017

Underlying

ENTLEntellus Medical Inc

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Entellus Medical Inc

 PRESS RELEASE
Free
ENTL Entellus Medica...

Multi-Center Market Research Confirms Nasal Valve Collapse as a Contri...

Multi-Center Market Research Confirms Nasal Valve Collapse as a Contributor for Most Nasal Obstruction Sufferers MENLO PARK, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- Entellus Medical Inc., now part of Stryker, today announced the publication of a multi-site market research study evaluating symptom severity for nasal airway obstruction (NAO) patients seen in otolaryngology (ENT) practices, and the prevalence of anatomical causes. Results show that the prevalence of nasal valve collapse (NVC) is comparable to septal deviation and turbinate hypertrophy across all patients evaluated and in t...

June 28, 2018 1 EN
 PRESS RELEASE
Free
ENTL Entellus Medica...

Entellus Medical announces publication of the 1-year results of a rand...

Entellus Medical announces publication of the 1-year results of a randomized controlled trial comparing balloon dilation with medical therapy for treatment of persistent Eustachian tube dysfunction PLYMOUTH, Minn., June 19, 2018 (GLOBE NEWSWIRE) -- Entellus Medical, Inc., now a part of Stryker, today announced Otology and Neurotology published results from a study that compares balloon dilation with ongoing medical therapy for the treatment of persistent Eustachian tube dysfunction (ETD). Over 7.3 million people have symptoms of Eustachian tube dysfunction, including ear pain and pressure...

June 19, 2018 1 EN
Free Trial
ENTL Entellus Medica...

Three Directors sold 3,450,975 shares at 24.000USD.

Three Directors at Entellus Medical Inc sold 3,450,975 shares at 24.000USD. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...

ENTL ENTELLUS MEDICAL INC
03/02/18 March 2, 2018 1 EN
 PRESS RELEASE
Free
ENTL Entellus Medica...

The Law Offices of Vincent Wong Notifies Investors of a Complaint on B...

NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong announce the commencement of a class action concerning the sale of Entellus Medical, Inc. (NASDAQ:ENTL) to Stryker Corporation (NYSE:SYK). Under the terms of the deal, Entellus shareholders will receive $24.00 in cash for each share of Entellus stock they own. The action concerns whether the Entellus Board of Directors breached their fiduciary duties to Entellus stockholders by failing to adequately shop the Company before entering into this transaction and whether ...

January 17, 2018 1 EN
 PRESS RELEASE
Free
ENTL Entellus Medica...

The Law Offices of Vincent Wong Notifies Investors of an Investigation...

NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong are investigating the Board of Directors of Entellus Medical, Inc. (NASDAQ:ENTL) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Stryker Corporation (NYSE: SYK). Under the terms of the deal, Entellus shareholders will receive $24.00 in cash for each share of Entellus stock they own. The investigation concerns whether the Entellus Board of Directors breached their fiduciary duties to Entellus stoc...

December 13, 2017 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch